Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| 10-K | 10-K | 10-K | 10-K | S-1/A |
Revenues | 0.7 | 3.5 | 3.7 | 2.3 | 0.0 |
Revenue growth | -80.3% | -5.4% | 58.9% | | |
Cost of goods sold | 0.6 | 3.5 | 3.7 | 1.3 | 0.0 |
Gross profit | 0.1 | 0.0 | 0.0 | 1.0 | 0.0 |
Gross margin | 13.0% | 0.0% | 0.0% | 44.9% | |
Selling, general and administrative [+] | 11.3 | 10.9 | 8.4 | 4.3 | 3.3 |
General and administrative | 11.3 | 10.9 | 8.4 | 4.3 | 3.3 |
Research and development | 27.9 | 29.9 | 22.4 | 14.4 | 5.7 |
Other operating expenses | -2.2 | -2.7 | -4.8 | | |
EBITDA [+] | -36.6 | -38.0 | -25.9 | -17.6 | -9.0 |
EBITDA growth | -3.5% | 46.6% | 47.5% | 95.4% | |
EBITDA margin | -5292.5% | -1082.5% | -698.4% | -752.4% | |
Depreciation and amortization | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 |
EBIT [+] | -36.8 | -38.1 | -26.1 | -17.7 | -9.0 |
EBIT growth | -3.5% | 46.2% | 47.2% | 96.0% | |
EBIT margin | -5315.9% | -1087.3% | -703.3% | -758.8% | |
Non-recurring items | 0.7 | 1.1 | 3.7 | | |
Interest income, net [+] | 0.1 | -0.3 | 0.1 | 0.2 | |
Interest expense | | 0.3 | | | |
Interest income | 0.1 | | 0.1 | 0.2 | |
Other income (expense), net | | | | | 0.4 |
Pre-tax income | -37.4 | -39.5 | -29.7 | -17.5 | -8.6 |
Income taxes | 2.1 | 1.9 | 0.4 | 0.3 | 0.3 |
Net income | -38.0 | -40.3 | -30.1 | -17.8 | -8.9 |
Net margin | -5493.2% | -1148.1% | -813.0% | -762.3% | |
|
Basic EPS [+] | ($2.46) | ($2.80) | ($3.06) | ($3.57) | ($1.80) |
Growth | -12.0% | -8.6% | -14.4% | 98.8% | |
Diluted EPS [+] | ($2.46) | ($2.80) | ($3.06) | ($3.57) | ($1.80) |
Growth | -12.0% | -8.6% | -14.4% | 98.8% | |
|
Dividends per share | $0.04 | | | | |
|
Shares outstanding (basic) [+] | 15.4 | 14.4 | 9.9 | 5.0 | 4.9 |
Growth | 7.3% | 46.0% | 98.0% | 0.9% | |
Shares outstanding (diluted) [+] | 15.4 | 14.4 | 9.9 | 5.0 | 4.9 |
Growth | 7.3% | 46.0% | 98.0% | 0.9% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|